TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

The Supply, Delivery, Installation and Maintenance of Laboratory Equipment

Laboratory
optical and precision equipments (excl. glasses)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "The Supply, Delivery, Installation and Maintenance of Laboratory Equipment". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.5Bids / Report
33.3% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 8 active published awards; 6 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Aug 2021, 13:22 BST
Last source update20 Aug 2021, 13:22 BST
Recurring procurementNot published
ClassificationLaboratory, optical and precision equipments (excl. glasses)
Delivery area
OCIDocds-h6vhtk-02d76a
What is being bought
Medicines Discovery Catapult Ltd (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
What changed
From the official release history
  1. Status changed to complete
    20 Aug 2021, 13:22 BST
  2. Official notice release published
    20 Aug 2021, 13:22 BST
  3. Buyer information updated
    20 Aug 2021, 13:22 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    MDC are expanding their PCR capability and thus require the supply and installation of the below equipment for COVID-PCR testing via the Accredited assay: 5 x Thermo Kingfisher flex 3 x Quant Studio 7’s MDC Ltd is a ISO accreditation laboratory within the terms of the ISO 15189 Accreditation we must use the above equipment.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Aug 2021, 13:22 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 23 Jul 2021, 00:00 BST · £500,000
Commercial outcome and competition
Awards
Life Technologies Limited
Not published · Not published · active
Contracts
Contract
£500,000 · signed 23 Jul 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-1022
View buyer profile
  • Medicines Discovery Catapult
    buyer

    Block 35, Mereside, Alderley Park, Cheshire, UKD62, SK10 4TG
    +44 1625708394
  • Life Technologies Limited
    supplier

    3 Fountain Drive, Inchinnan Business Park, Paisley, UKD62, PA4 9RF
  • Medicines Discovery Catapult
    reviewBody

    Alderley Edge
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleMDC is an ISO 15189 Accreditation Laboratory and our commercial contracts dictate that we must hold / retain this status. The ISO 15189 Accreditation has been reviewed / awarded on the current equipment within the MDC Laboratory including the Thermo Fisher Kingfishers, as such we are unable to install 'other' equipment into the laboratory without this affecting the ISO 15189 Accreditation. The installation of 'other' equipment would invalidate the ISO 15189 Accreditation and the MDC would be have to be reassessed for the ISO 15189 Accreditation and the introduction of 'other' equipment. The need to stay with the current equipment supplier is founded on the use of a single assay and protocol under our UKAS accreditation; this ensures that 1) Workflow is consistent to one method 2) Mistakes cannot occur due to confusion of different methods, training a workforce of more than 700FTE on new systems, sops and complex workflows runs risks that errors will be introduced 3) That the quality standards required by UKAS are continued to be met 4) We maintain consistency with reagent provider CE-certification on this equipment